Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-03-26

Clinical Trial Update: The Safety of Remote DBS Programming System [NA]

View source ↗

Summary

The clinical trial evaluating the safety of a remote deep brain stimulation programming system for Parkinson's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ruijin Hospital | Conditions: Parkinson Disease | NA | Status: WITHDRAWN